Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) EBT (2016 - 2025)

Historic EBT for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$2.6 million.

  • Firefly Neuroscience's EBT rose 3847.05% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.2 million, marking a year-over-year decrease of 17326.8%. This contributed to the annual value of -$10.5 million for FY2024, which is 30192.16% down from last year.
  • Latest data reveals that Firefly Neuroscience reported EBT of -$2.6 million as of Q3 2025, which was up 3847.05% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, Firefly Neuroscience's EBT peaked at $456438.0 during Q2 2023, and registered a low of -$12.9 million during Q1 2025.
  • Its 5-year average for EBT is -$2.0 million, with a median of -$1.1 million in 2022.
  • Per our database at Business Quant, Firefly Neuroscience's EBT soared by 31435.58% in 2021 and then crashed by 385117.13% in 2022.
  • Quarter analysis of 5 years shows Firefly Neuroscience's EBT stood at -$2.4 million in 2021, then soared by 57.39% to -$1.0 million in 2022, then decreased by 4.32% to -$1.1 million in 2023, then tumbled by 251.58% to -$3.8 million in 2024, then surged by 30.24% to -$2.6 million in 2025.
  • Its EBT stands at -$2.6 million for Q3 2025, versus -$1.8 million for Q2 2025 and -$12.9 million for Q1 2025.